Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. - Wikidata - awgldk - TriplyDB

Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.

Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.

http://www.wikidata.org/entity/Q37125927

about

Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A Review The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells β-catenin stabilization in gonadotropes impairs FSH synthesis in male mice in vivo.Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor.Follistatin promotes adipocyte differentiation, browning, and energy metabolism ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells.Signaling pathways implicated in androgen regulation of endocortical bone Topical androgen antagonism promotes cutaneous wound healing without systemic androgen deprivation by blocking β-catenin nuclear translocation and cross-talk with TGF-β signaling in keratinocytes.Transcriptome analysis of the dihydrotestosterone-exposed fetal rat gubernaculum identifies common androgen and insulin-like 3 targets Trenbolone enhances myogenic differentiation by enhancing β-catenin signaling in muscle-derived stem cells of cattle.Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study Selective androgen receptor modulators as function promoting therapies.Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle.Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors Sarcopenia and Androgens: A Link between Pathology and Treatment.Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).Proteomic identification of mitochondrial targets of arginase in human breast cancer.Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy.Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis.Molecular targets of androgen signaling that characterize skeletal muscle recovery and regeneration.GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.Oxidative stress specifically downregulates survivin to promote breast tumour formation Testosterone improves the regeneration of old and young mouse skeletal muscle Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter Inhibition of in vitro and in vivo brown fat differentiation program by myostatin.Nuclear receptor regulation of stemness and stem cell differentiation.Clinical and Therapeutic Implications of Follistatin in Solid Tumours.Feedback Activation of Basic Fibroblast Growth Factor Signaling via the Wnt/β-Catenin Pathway in Skin Fibroblasts.Androgen effects on skeletal muscle: implications for the development and management of frailty.Follistatin as potential therapeutic target in prostate cancer.Molecular mechanisms of muscle plasticity with exercise.Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages.Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily.Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.Cardiomyocyte regeneration.Crosstalk between adipokines and myokines in fat browning.Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β.

P2860

Q26744739-8CF71CBC-C8E6-4CD4-A37C-50928458D2C7 Q26765892-6BAC325F-6CAC-4C95-8B10-559D7E63670F Q30361776-BDE9BCC6-D75C-411E-ADE6-EF631505D818 Q30409171-3446FEFE-DFD0-4D5A-8662-C5E4E892CCF0 Q30424724-83441629-342C-4218-8CB5-574805998485 Q30572723-4FED42E5-AB5D-49B0-A7C6-6C43FC8ADE4C Q30576405-25E3F54E-35FD-4EEB-B42D-64B304A5A3AD Q33664050-1E620E2D-AB68-47EE-A199-910BF41A7C16 Q33772279-FAC9BBA2-B9C3-4B9C-9DDA-F89181A4213C Q33826110-DC940D48-BAE7-4888-B602-06D4F20A59EB Q33909968-F00C013B-234B-4954-A724-15F7DFC27A74 Q33984860-3C7A8C0C-CC48-42EF-A6A2-C6634B6861C1 Q34007493-52057895-C2E9-4208-B981-1E211F70B5F7 Q34045389-B52EB0C8-F20D-4CF3-96A6-E5998A517256 Q34529037-9ABE60A1-B202-4E67-871D-085FFB8120E7 Q34643472-8B662734-E334-4C57-BBF4-909DDBD7500A Q34730659-41CA5EC0-E69C-4D47-A7C2-6D4CF21FA1C6 Q35006864-23A2D4B7-0DC7-4008-A1EF-363B3388F1BB Q35041221-B0944D27-FC6C-4230-8A2F-A85AABD52961 Q35093119-912151D1-2746-4704-A600-07E90722B136 Q35690909-84495B44-9397-4174-8C40-C8200310C55D Q35737086-7AD994B9-19A8-4151-B361-80CC47EAA8E3 Q36140346-69B0BC99-C38F-4E06-B69D-057730E0F643 Q36225026-C04C3F99-59F1-483B-805A-36E2B4CB17C1 Q36663651-24211AA6-CBF2-423D-B16A-277797C61A45 Q36686910-E1D09A51-F702-422F-ABAF-9C9B9F509A8A Q36947716-7FC0DD2E-42C8-4E5F-AB42-68C26F42B0D4 Q37075756-38D05832-9A4B-48EF-9655-931068C7C603 Q37337890-83E8F519-E456-48C3-938F-9AC30A97A7E9 Q37569979-D9C65ED9-28FD-458E-9405-147A15BD6A63 Q37622023-A7C10910-C912-46D3-ACCA-B1EC76A68A67 Q37639192-F0E176E5-587E-410A-A112-DD6F2BBB0A87 Q38086102-404E4EA0-3919-455A-8C51-CBEB73786F98 Q38111713-A6978E65-ACF8-451D-9475-B068D55DDE24 Q38205189-64BB7AA8-BEE9-4953-913C-58A4ED75F614 Q38273056-30CE5C6C-E1AE-4B66-BF75-ED070C110345 Q38433368-21A075A3-2D1D-4E45-BCB4-C45119A29D16 Q38588589-AA351FD0-CE7B-43A4-80D0-8E12A8DEEA7B Q38797210-905BFB47-4BF3-45D2-B8D0-D8C8A03034AB Q39669643-D4E50A9F-508F-4739-B449-451BC6DDE0B8

P2860

Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.

http://www.wikidata.org/entity/Q37125927

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regulation of myogenic differe ...... actor-beta signaling pathways.

@en

Regulation of myogenic differe ...... actor-beta signaling pathways.

@nl

type

label

Regulation of myogenic differe ...... actor-beta signaling pathways.

@en

Regulation of myogenic differe ...... actor-beta signaling pathways.

@nl

prefLabel

Regulation of myogenic differe ...... actor-beta signaling pathways.

@en

Regulation of myogenic differe ...... actor-beta signaling pathways.

@nl

P1433

Q37125927-83EE4CAA-B1B9-416F-B9E3-2CC1129F4A96

P1476

Q37125927-F8492040-D18C-434E-A238-A34FF953EC3A

P2093

Q37125927-3816D2A1-C3F2-4F7F-83F7-EA7B9150CCC2

Q37125927-3DF49C55-03C6-4EC0-B949-984F3A5AF97A

Q37125927-5B7B2C15-146B-44F8-8D3B-224D12EB7E59

Q37125927-83C19C35-DD0B-4BD9-9B9F-75068B504BAE

Q37125927-877D48E2-F5EC-4BEC-AB11-E3AD22474F25

Q37125927-8B457116-74B7-4FA9-853D-A65916638409

Q37125927-8B566501-6C2A-4654-8505-86BBB0BF6D2F

Q37125927-B21309FD-B85A-487F-A41E-A4588F9D6CF5

Q37125927-FD815AB2-5A82-482E-ABAE-13FB467F887D

P2860

Q37125927-02F5248B-6F35-4570-9E8E-9FFE799E208B

Q37125927-0A97D2B8-2F65-469C-9031-4A289E5C4CCC

Q37125927-16323CA7-E71B-4643-B8E8-C1908C85E73E

Q37125927-181289AE-6E48-4578-902B-165D88550428

Q37125927-198FCF86-45AF-477F-82F1-818539EB7862

Q37125927-246A7C8C-02BD-491B-ACDB-10C35ED13206

Q37125927-2C5CD1D4-D26E-40B4-8840-F6CF979F6231

Q37125927-3195D282-5A30-4A3D-84B3-EE467EEEF089

Q37125927-33EAF4E9-D112-47CA-B824-942DFF1B0C66

Q37125927-391300EF-F88C-4AAB-801D-A65C6523D5BA

P304

Q37125927-1F6BCCB6-287B-4E00-BFCD-DDBC3598C8AC

P31

Q37125927-E33E32B6-2D75-40A7-AD02-6FBA1ED97104

P356

Q37125927-833EBDC4-320F-41E1-89FD-424C7661A4E2

P407

Q37125927-CEFF006B-7741-46EE-B32E-709092AAA2B3

P433

Q37125927-17A6FCC8-D7FE-47F9-ABC8-F5B5E15877CF

P478

Q37125927-7B73B03C-3E71-4E6C-9410-A868ABE5956D

P50

Q37125927-B407062C-FF2F-456C-8422-0D321C1A15AD

P577

Q37125927-A0E2D7DC-D76E-49E3-BE8B-20F37D7E88CB

P5875

Q37125927-47E69870-9394-4770-8A88-FA0E351B703C

P698

Q37125927-3A3A8AAD-8A29-4CE9-807E-0E1A632B6AAE

P932

Q37125927-83118637-7525-4FBA-9B5E-53271DADDEF1

P356

P1433

P1476

Regulation of myogenic differe ...... actor-beta signaling pathways.

@en

P2093

Jorge N Artaza

http://www.w3.org/2001/XMLSchema#string

Melissa Braga

http://www.w3.org/2001/XMLSchema#string

Rajan Singh

http://www.w3.org/2001/XMLSchema#string

Ravi Jasuja

http://www.w3.org/2001/XMLSchema#string

Satyesh K Sinha

http://www.w3.org/2001/XMLSchema#string

Shehla Pervin

http://www.w3.org/2001/XMLSchema#string

Tripathi B Rajavashisth

http://www.w3.org/2001/XMLSchema#string

Venkatesh Krishnan

http://www.w3.org/2001/XMLSchema#string

Wayne E Taylor

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm

Inhibition of adipogenesis by Wnt signaling

Structural basis for the inhibition of activin signalling by follistatin.

Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium

A transcriptional response to Wnt protein in human embryonic carcinoma cells

Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells

Linking beta-catenin to androgen-signaling pathway

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins

Beta-catenin is essential and sufficient for skeletal myogenesis in P19 cells

P304

1259-1268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2008-0858

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

Shalender Bhasin

P577

2008-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23411089

http://www.w3.org/2001/XMLSchema#string

P698

18948405

http://www.w3.org/2001/XMLSchema#string

P932

2654730

http://www.w3.org/2001/XMLSchema#string